List of Tables
    Table 1. Standard Lancets CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Standard Lancets Market Trends
    Table 3. Standard Lancets Market Drivers
    Table 4. Standard Lancets Market Challenges
    Table 5. Standard Lancets Market Restraints
    Table 6. Global Standard Lancets Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Standard Lancets Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Standard Lancets Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Standard Lancets Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Standard Lancets Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Standard Lancets Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Standard Lancets Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Standard Lancets Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Standard Lancets Sales Share by Manufacturer, 2017-2022
    Table 15. Global Standard Lancets Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Standard Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Standard Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Standard Lancets as of 2021)
    Table 18. Top Players of Standard Lancets in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Standard Lancets Product Type
    Table 20. Date of International Manufacturers Enter into Standard Lancets Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Standard Lancets Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Standard Lancets Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Standard Lancets Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Standard Lancets Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Standard Lancets Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Standard Lancets Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Standard Lancets Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Standard Lancets Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Standard Lancets Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Standard Lancets Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Standard Lancets Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Standard Lancets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Standard Lancets Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Standard Lancets Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Standard Lancets Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Standard Lancets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Standard Lancets Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Standard Lancets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Standard Lancets Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Standard Lancets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Roche Corporation Information
    Table 43. Roche Description and Business Overview
    Table 44. Roche Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Roche Standard Lancets Product
    Table 46. Roche Recent Development
    Table 47. Lifescan Corporation Information
    Table 48. Lifescan Description and Business Overview
    Table 49. Lifescan Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Lifescan Product
    Table 51. Lifescan Recent Development
    Table 52. BD Corporation Information
    Table 53. BD Description and Business Overview
    Table 54. BD Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. BD Product
    Table 56. BD Recent Development
    Table 57. Bayer Corporation Information
    Table 58. Bayer Description and Business Overview
    Table 59. Bayer Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Bayer Product
    Table 61. Bayer Recent Development
    Table 62. Abbott Corporation Information
    Table 63. Abbott Description and Business Overview
    Table 64. Abbott Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Abbott Product
    Table 66. Abbott Recent Development
    Table 67. B. Braun Corporation Information
    Table 68. B. Braun Description and Business Overview
    Table 69. B. Braun Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. B. Braun Product
    Table 71. B. Braun Recent Development
    Table 72. ARKRAY Corporation Information
    Table 73. ARKRAY Description and Business Overview
    Table 74. ARKRAY Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. ARKRAY Product
    Table 76. ARKRAY Recent Development
    Table 77. Terumo Corporation Information
    Table 78. Terumo Description and Business Overview
    Table 79. Terumo Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Terumo Product
    Table 81. Terumo Recent Development
    Table 82. I-SENS Corporation Information
    Table 83. I-SENS Description and Business Overview
    Table 84. I-SENS Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. I-SENS Product
    Table 86. I-SENS Recent Development
    Table 87. Nipro Corporation Information
    Table 88. Nipro Description and Business Overview
    Table 89. Nipro Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Nipro Product
    Table 91. Nipro Recent Development
    Table 92. Omron Corporation Information
    Table 93. Omron Description and Business Overview
    Table 94. Omron Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Omron Product
    Table 96. Omron Recent Development
    Table 97. Infopia Corporation Information
    Table 98. Infopia Description and Business Overview
    Table 99. Infopia Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Infopia Product
    Table 101. Infopia Recent Development
    Table 102. AgaMatrix Corporation Information
    Table 103. AgaMatrix Description and Business Overview
    Table 104. AgaMatrix Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. AgaMatrix Product
    Table 106. AgaMatrix Recent Development
    Table 107. Smiths Medical Corporation Information
    Table 108. Smiths Medical Description and Business Overview
    Table 109. Smiths Medical Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Smiths Medical Product
    Table 111. Smiths Medical Recent Development
    Table 112. Sarstedt Corporation Information
    Table 113. Sarstedt Description and Business Overview
    Table 114. Sarstedt Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Sarstedt Product
    Table 116. Sarstedt Recent Development
    Table 117. SANNUO Corporation Information
    Table 118. SANNUO Description and Business Overview
    Table 119. SANNUO Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. SANNUO Product
    Table 121. SANNUO Recent Development
    Table 122. Yicheng Corporation Information
    Table 123. Yicheng Description and Business Overview
    Table 124. Yicheng Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. Yicheng Product
    Table 126. Yicheng Recent Development
    Table 127. Yuwell Corporation Information
    Table 128. Yuwell Description and Business Overview
    Table 129. Yuwell Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. Yuwell Product
    Table 131. Yuwell Recent Development
    Table 132. Greiner Bio One Corporation Information
    Table 133. Greiner Bio One Description and Business Overview
    Table 134. Greiner Bio One Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 135. Greiner Bio One Product
    Table 136. Greiner Bio One Recent Development
    Table 137. Edan Corporation Information
    Table 138. Edan Description and Business Overview
    Table 139. Edan Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 140. Edan Product
    Table 141. Edan Recent Development
    Table 142. Narang Medical Corporation Information
    Table 143. Narang Medical Description and Business Overview
    Table 144. Narang Medical Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 145. Narang Medical Product
    Table 146. Narang Medical Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Standard Lancets Customers List
    Table 150. Standard Lancets Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Standard Lancets Product Picture
    Figure 2. Global Standard Lancets Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Standard Lancets Market Size 2017-2028 (US$ Million)
    Figure 4. Global Standard Lancets Sales 2017-2028 (K Units)
    Figure 5. United States Standard Lancets Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Standard Lancets Market Size 2017-2028 (US$ Million)
    Figure 7. United States Standard Lancets Sales 2017-2028 (K Units)
    Figure 8. United States Standard Lancets Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Standard Lancets Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Standard Lancets Report Years Considered
    Figure 11. Product Picture of Needle
    Figure 12. Product Picture of Blade
    Figure 13. Global Standard Lancets Market Share by Type in 2022 & 2028
    Figure 14. Global Standard Lancets Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Standard Lancets Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Standard Lancets Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Standard Lancets Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Standard Lancets Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Standard Lancets Market Share by Type in 2022 & 2028
    Figure 20. United States Standard Lancets Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Standard Lancets Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Standard Lancets Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Standard Lancets Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Standard Lancets Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Hospitals and Clinics
    Figure 26. Product Picture of Homecare Settings
    Figure 27. Product Picture of Others
    Figure 28. Global Standard Lancets Market Share by Application in 2022 & 2028
    Figure 29. Global Standard Lancets Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Standard Lancets Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Standard Lancets Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Standard Lancets Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Standard Lancets Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Standard Lancets Market Share by Application in 2022 & 2028
    Figure 35. United States Standard Lancets Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Standard Lancets Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Standard Lancets Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Standard Lancets Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Standard Lancets Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Standard Lancets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Standard Lancets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Standard Lancets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Standard Lancets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Standard Lancets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Standard Lancets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Standard Lancets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Standard Lancets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Standard Lancets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Standard Lancets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Standard Lancets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Standard Lancets Value Chain
    Figure 74. Standard Lancets Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed